Washington (AFP) – The US Food and Drug Administration on Thursday said it was ordering all products produced by Juul Labs off the market after finding the vaping giant had failed to address certain safety concerns. The decision, which Juul said it would appeal, clears the way for rival brands to increase their share of the market it once dominated. It is also a blow for tobacco giant Altria, maker of Marlboro cigarettes, which acquired a 35 stake in Juul in 2018 to diversify its business strategy in the face of falling smoking rates. “Today’s action is further progress on the FDA’s commitment…